Efficient reprogramming of fibroblasts into iPSCs using mRNA technology
Dec
5
2023
On demand

Efficient reprogramming of fibroblasts into iPSCs using mRNA technology

Tuesday 08:00 PST / 11:00 EST / 16:00 GMT / 17:00 CET
Sponsor
Efficient reprogramming of fibroblasts into iPSCs using mRNA technology

Join us for an informative webinar on creating induced pluripotent stem cells (iPSCs), which sheds light on the strengths of the mRNA technique compared to other methods.

Discover the new Miltenyi Biotec mRNA reprogramming workflow and its myriad of benefits including enhanced efficiency, safety, and reproducibility in a streamlined process that ensures high-quality iPSCs.

Hannah Johannsen and Parivash Nouri (Miltenyi Biotec) will provide a comprehensive overview of the entire reprogramming workflow — from fibroblast collection to iPSC generation, isolation, and quality control.

Sebastian Diecke (Max Delbrück Center, Berlin) will showcase outcomes achieved in his lab through the application of the technique.

  • Understand each step within the reprogramming workflow
  • Learn how to optimize your reprogramming experiments
  • Gain practical insights into reprogramming or iPSC generation from first-hand experience
Sebastian Diecke
Sebastian Diecke
Stem Cell Core Director at Max Delbrück Center For Molecular Medicine

Dr Sebastian Diecke is working as a head of the Pluripotent Stem cell Platform at the Max Delbrück Center in Berlin. His research involves reprogramming, differentiation, and genome editing of human induced pluripotent stem cells (hiPSCs).

Hannah Johannsen
Hannah Johannsen
Group Leader & Project Manager, R&D, Molecular Technologies & Stem Cell Therapy at Miltenyi Biotec

Hannah Johannsen has been with Miltenyi Biotec B.V. & Co.KG for 10 years and currently holds the position of a Group Lead in the R&D department with a focus on iPSC-technologies and cell sorting.

Parivash Nouri
Parivash Nouri
Global Product Manager for Pluripotent Stem Cells in Research at Miltenyi Biotec

During her PhD, Parivash conducted research on iPSCs and their differentiation into midbrain dopaminergic neurons. Currently, she holds the position of Application Product Manager for Pluripotent Stem Cells in research within the Global Marketing department.

SPEAKERS

Sebastian Diecke
Sebastian Diecke
Stem Cell Core Director at Max Delbrück Center For Molecular Medicine
Hannah Johannsen
Hannah Johannsen
Group Leader & Project Manager, R&D, Molecular Technologies & Stem Cell Therapy at Miltenyi Biotec
Parivash Nouri
Parivash Nouri
Global Product Manager for Pluripotent Stem Cells in Research at Miltenyi Biotec

You might also like

Same-section spatial multiomics: a platform for detailed analysis of the solid tumor TME

Same-section spatial multiomics: a platform for detailed analysis of the solid tumor TME

Emily Neil, Ariadna Pascual
27 June
in 60
Days
Register
Precision in production: optimizing monitoring and quality control for high-value plasmids

Precision in production: optimizing monitoring and quality control for high-value plasmids

Oleksandr Karpenko
6 June
in 39
Days
Register
Advancing cell therapy: innovations in polymer-based encapsulation and delivery

Advancing cell therapy: innovations in polymer-based encapsulation and delivery

Y Brudno, O Veiseh, M Delic-Schlumbohm et al.
5 June
in 38
Days
Register
Pure and simple: understanding LNP analytics for better mRNA-based drugs

Pure and simple: understanding LNP analytics for better mRNA-based drugs

Adam Crowe
29 May
in 31
Days
Register
Empowering patient care: in-process and quality control solutions for cellular therapies

Empowering patient care: in-process and quality control solutions for cellular therapies

Christin Tischner, Simon Lennartz
23 May
in 25
Days
Register